Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$705,399
+$15,951 QoQ
Shares Held
29,294
+19.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#1,526
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FAIRFIELD, BUSH & CO. holds $16,010,185 across 9 Drug Manufacturers - General names. PFE ranks #8 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,869 | $3,441,164 | |
| 2 | NVS |
Novartis AG
|
19,239 | $3,015,136 | |
| 3 | MRK |
Merck & Co., Inc.
|
20,842 | $2,678,197 | |
| 4 | JNJ |
Johnson & Johnson
|
8,732 | $2,217,666 | |
| 5 | ABBV |
AbbVie Inc.
|
7,031 | $1,769,280 | |
| 6 | AMGN |
Amgen Inc
|
2,933 | $1,062,097 | |
| 7 | NVO |
Novo Nordisk A S
|
18,073 | $866,419 | |
| 8 | PFE |
Pfizer Inc
This page
|
29,294 | $705,399 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $705,399 | 29,294 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $689,448 | 24,553 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $632,609 | 25,406 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $764,654 | 30,010 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $781,861 | 32,255 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $857,759 | 33,850 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $919,635 | 34,664 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $763,524 | 26,383 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $542,951 | 19,405 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $475,302 | 17,128 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $432,915 | 15,037 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $498,777 | 15,037 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,332,841 | 36,337 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,233,669 | 30,237 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $806,312 | 15,736 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $685,719 | 15,670 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $811,092 | 15,470 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $829,355 | 16,020 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $963,636 | 16,319 | Shares | Sole | 2022-05-12 | |
| 2021-09-30 | $1,400,792 | 32,569 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,141,435 | 29,148 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,056,032 | 29,148 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,091,342 | 29,648 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,098,466 | 29,931 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $978,744 | 29,931 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $976,946 | 29,931 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||